Rexam Establish Beverage Can JV and Acquire Pharmaceuticals Packaging Manufacturer in India

Rexam, the global consumer packaging company and the world’s leading beverage can maker, announces that it has established key footholds in the growing Indian packaging market. It has formed a joint venture with a quoted Indian company, the Hindustan Tin Works (HTW), to start up a beverage can plant and has also signed an agreement to acquire Truepack, a pharmaceutical packaging company.

Beverage can joint venture

The joint venture with HTW, in which Rexam will have a majority stake, represents a cash investment by Rexam of some £7m. The beverage can plant, the first of its kind in India, is located near Mumbai. It is expected to commence production in the final quarter of 2006 focusing primarily on the beer market.

The Indian beverage market is forecast to grow at 6% pa over the next three years and represents an attractive growth opportunity for beverage cans driven by a fast growing young population and substantial middle-class growth allied to further urbanisation and a developing supermarket culture.

Pharmaceutical acquisition

Truepack is one of the leading manufacturers of primary packaging in plastics for the pharmaceutical industry in India. The total cash consideration is £5m, including borrowings assumed. The acquisition is subject to Indian regulatory approvals

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.